These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19284468)

  • 1. The use of estrogen therapy in women's sexual functioning (CME).
    Nappi RE; Polatti F
    J Sex Med; 2009 Mar; 6(3):603-16; quiz 618-9. PubMed ID: 19284468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What happened to WHI: menopausal hormonal therapy in 2012.
    Hansen KA; Eyster KM
    Clin Obstet Gynecol; 2012 Sep; 55(3):706-12. PubMed ID: 22828102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vulvovaginal atrophy-related sexual dysfunction in postmenopausal women: an up-to-date review.
    Tan O; Bradshaw K; Carr BR
    Menopause; 2012 Jan; 19(1):109-17. PubMed ID: 22011753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different preparations of hormone therapy on sexual dysfunction in naturally postmenopausal women.
    Osmanağaoğlu MA; Atasaral T; Baltaci D; Bozkaya H
    Climacteric; 2006 Dec; 9(6):464-72. PubMed ID: 17085380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Estrogens and Estrogen-Like Compounds in Female Sexual Function and Dysfunction.
    Santoro N; Worsley R; Miller KK; Parish SJ; Davis SR
    J Sex Med; 2016 Mar; 13(3):305-16. PubMed ID: 26944462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
    Ziaei S; Moghasemi M; Faghihzadeh S
    Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial.
    Nijland EA; Weijmar Schultz WC; Nathorst-Boös J; Helmond FA; Van Lunsen RH; Palacios S; Norman RJ; Mulder RJ; Davis SR;
    J Sex Med; 2008 Mar; 5(3):646-56. PubMed ID: 18304284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen.
    Simon JA
    J Womens Health (Larchmt); 2011 Oct; 20(10):1453-65. PubMed ID: 21819250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Aging and sexuality in women].
    Nappi RE; Albani F; Valentino V; Polatti F; Chiovato L; Genazzani AR
    Minerva Ginecol; 2007 Jun; 59(3):287-98. PubMed ID: 17576405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical aspects in the management of vaginal atrophy and sexual dysfunction in perimenopausal and postmenopausal women.
    Goldstein I; Alexander JL
    J Sex Med; 2005 Sep; 2 Suppl 3():154-65. PubMed ID: 16422792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and management of women's sexual dysfunctions: problematic desire and arousal.
    Basson R; Brotto LA; Laan E; Redmond G; Utian WH
    J Sex Med; 2005 May; 2(3):291-300. PubMed ID: 16422860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a continuous-combined regimen of low-dose hormone therapy (oestradiol and norethindrone acetate) and tibolone on the quality of life in symptomatic postmenopausal women: a double-blind, randomised study.
    Polisseni AF; Andrade AT; Ribeiro LC; Castro IQ; Brandão M; Polisseni F; Guerra Mde O
    Maturitas; 2013 Feb; 74(2):172-8. PubMed ID: 23201326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tibolone on sexual function in late postmenopausal women.
    Kamenov ZA; Todorova MK; Christov VG
    Folia Med (Plovdiv); 2007; 49(1-2):41-8. PubMed ID: 18018469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What's new in the world of postmenopausal sex?
    Iglesia CB
    Curr Opin Obstet Gynecol; 2016 Oct; 28(5):449-54. PubMed ID: 27517339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Female sexual dysfunction and use of hormone therapy in postmenopausal women.
    Kovalevsky G
    Semin Reprod Med; 2005 May; 23(2):180-7. PubMed ID: 15852204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clitoral circulation in postmenopausal women with sexual dysfunction: a pilot randomized study with hormone therapy.
    Nappi RE; Ferdeghini F; Sampaolo P; Vaccaro P; De Leonardis C; Albani F; Salonia A; Polatti F
    Maturitas; 2006 Oct; 55(3):288-95. PubMed ID: 16730929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2007; 14(3 Pt 1):355-69; quiz 370-1. PubMed ID: 17438512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects of progestins, androgens, and tibolone for menopausal symptoms.
    Liu JH
    Am J Med; 2005 Dec; 118 Suppl 12B():88-92. PubMed ID: 16414332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of hormone therapy regimens, oral and vaginal estradiol, estradiol + drospirenone and tibolone, on sexual function in healthy postmenopausal women.
    Cayan F; Dilek U; Pata O; Dilek S
    J Sex Med; 2008 Jan; 5(1):132-8. PubMed ID: 17961145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.